Intravenous Iron Therapy

Aetna covers IV iron (Ferrlecit, INFeD, Venofer, Injectafer, Feraheme, Monoferric) for documented iron‑deficiency anemia per labeled indications but restricts Feraheme and Injectafer (and Feraheme for peritoneal/NDD CKD) to cases with contraindication, intolerance, or ineffective response to lower‑cost alternatives—or when those alternatives lack the required labeled indication; IV iron is contraindicated/experimental for genetic or secondary hemochromatosis. Precertification is required for Injectafer, Monoferric and Feraheme, and approval is contingent on age‑specific and indication‑specific criteria (e.g., CKD, heart failure, perioperative use, cancer/chemotherapy).

"D62 Acute posthemorrhagic anemia (note: listed in ICD-10 codes not covered for indications in the CPB)"

Sign up to see full coverage criteria, indications, and limitations.